Clinical Trial Update: Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports termination of a Phase 1/2 study evaluating the SmartMatrix Dermal Replacement Scaffold for basal cell carcinoma and squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Squamous Cell Carcinoma

Drugs mentioned

• SmartMatrix Dermal Replacement Scaffold

Snippet

Sponsor: Smart Matrix Limited | Conditions: Basal Cell Carcinoma, Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED